Healthcare

Assessing the Socioeconomic Impact of Alzheimer's Disease in western Europe and Canada

May 03, 2017

Europe, North America

May 03, 2017

Europe, North America
Edel McCormack

Deputy editor, EMEA

Edel is a deputy editor for The Economist Intelligence Unit's Thought Leadership division in EMEA. She works on bespoke research and thought leadership programmes in the areas of finance, healthcare and sustainability. From 2013 to October 2015 she worked as editorial coordinator supporting the EIU's Country Analysis, Custom Research and Global Forecasting teams. Additionally, she works as a freelance political and economics contributor covering politics, economics and industry trends in Africa. She holds an International BA in English and French, and Masters in Media and International Conflict.  

Contact

Developing national strategies on dementia is necessary to improving co-ordination across healthcare and social care service providers.

Assessing the socioeconomic impact of Alzheimer’s in western Europe and Canada is a report by The Economist Intelligence Unit, sponsored by Eli Lilly, which examines how healthcare systems and governments in western Europe and Canada are responding to the growing pressures that Alzheimer’s disease and other dementias are placing on their economy, society and healthcare systems.

The findings of this report are based on research carried out by The Economist Intelligence Unit and include insights from leading dementia experts in academia and the medical profession, as well as patient association leaders. 

 

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week